Abstract
We must remember that there are many subclinical cases of obstructive sleep apnea (OSA), even if the patient or family members typically become aware of it through symptoms such as snoring and excessive daytime sleepiness (EDS). EDS is a common symptom among hypertensive patients. This interesting and remarkable systematic review aims to comprehensively survey the current literature on the prevalence and association of EDS among hypertensive patients. PubMed, SCOPUS, Web of Science, and Science Direct were systematically searched for relevant literature. Rayyan QRCI (Rayyan Systems Inc., Cambridge, MA) was employed throughout this comprehensive process. This review included nine studies with a total of 58,517 patients, and 34,398 (58.8%) were males. EDS prevalence among hypertensive patients ranged from 12.1% to 88.3%. This review stated that individuals with hypertension (HTN) had EDS that was worse than that of patients with normotension. In one of the studies included in this analysis, sympathovagal imbalance was noted alongside EDS and HTN. Older age, primary education, being overweight, working, obesity, depression, and having had the condition for longer are all associated with EDS in HTN patients.
Keywords: sleep apnea and hypertension, obstructive sleep apnea (osa), hypertensive patients, hypertension, excessive daytime sleepiness
Introduction and background
Cardiovascular morbidity and mortality are significantly impacted by hypertension (HTN), which is a key risk factor for cardiovascular disease, including stroke [1-3]. HTN is considered high intravascular pressure, impairing circadian blood pressure (BP). In addition, it has been shown to contribute to poor clinical outcomes, potentially [4-6]. According to Mills et al. [7], it affected 1.39 billion people worldwide in 2010 (31% of all adults), a rise in prevalence of 5.2% from 2000 to 2017.
BP exhibits a consistent circadian rhythm characterized by a decrease of 10%-20% during nighttime compared to daytime, primarily due to inherent neuroendocrine oscillations and various contributing factors [5]. People with HTN had lower-quality sleep than individuals with normal BP, according to earlier research [8-10]. Additionally, it has been demonstrated that sleep issues are linked to greater rates of all-cause mortality [11], as well as an increased risk of HTN [10,12], vascular inflammation [13], and uncontrolled and treatment-resistant HTN [14]. According to the findings of a study by Li et al. [15], treating sleep disturbances in hypertensive patients can lower BP.
About one-third of the population experiences sleep difficulties, such as insomnia or EDS, which makes them a serious therapeutic issue. The most common definition of insomnia is the existence of a subjective report of trouble falling asleep, which results in insufficient or poor-quality sleep [16].
EDS is a prevalent clinical issue. It is among the most significant effects of sleep disorders and is linked to a lower quality of life, traffic accidents, and workplace mishaps [17]. EDS is characterized by an almost daily inability to maintain vigilance and alertness for the majority of the day when the individual is expected to be awake, with sleep occurring accidentally or at the wrong times. According to estimates [18-21], it affects between 10% and 20% of the general population and up to 68% of certain patient populations [21]. Numerous studies, particularly those involving people who had sleep apnea syndrome (SAS), revealed an independent relationship between EDS and HTN [21,22]. This systematic review aims to comprehensively investigate the recent literature on the prevalence and association of EDS among hypertensive patients.
Review
Methodology
This systematic review complied with established criteria (Preferred Reporting Items for Systematic Reviews and Meta-Analyses, PRISMA) [23].
Study Design and Duration
This systematic review was conducted in September 2023.
Search Strategy
A thorough search was conducted across four main databases, including PubMed, SCOPUS, Web of Science, and Science Direct, to locate the pertinent literature. We limited our search to English and considered each database's particular needs. The studies corresponding to the following keywords were located using PubMed Mesh terms; "Excessive daytime sleepiness," "Sleep disturbances," and "Hypertension." The Boolean operators "OR" and "AND" matched the required keywords. Publications with full English text, available free articles, and human trials were among the search results.
Selection Criteria
We considered the following criteria for inclusion in this review: studies that investigated the recent literature on the prevalence and association of EDS among patients with arterial HTN; studies that included adults and adolescents; studies conducted within the last five years (2019-2023) on human subjects; studies in the English language; and free accessible articles.
Data Extraction
Rayyan QCRI (Rayyan Systems Inc., Cambridge, MA) was used to check the output of the search technique for duplication [24]. The researchers assessed the titles' and abstract relevance by altering the combined search results with the inclusion/exclusion criteria. The reviewers thoroughly scrutinized each paper that matched the inclusion criteria. The writers discussed dispute-resolution approaches. The authorized study was uploaded using a previously generated data extraction form. The authors extracted data about the study titles, authors, study year, country, participants, gender, objectives, prevalence of EDS, and main outcomes. A separate sheet was created for the risk of bias assessment.
Strategy for Data Synthesis
Summary tables were created using data from relevant studies to provide a qualitative interpretation of the findings and study components. After retrieving the data for the systematic review, the most efficient strategy to use the data from the included study articles was chosen.
Risk of Bias Assessment
The quality of the included studies was assessed using the ROBINS-I risk of bias assessment approach for non-randomized trials of treatments [25]. Confounding, participant selection for the study, classification of interventions, deviations from intended interventions, missing data, assessment of outcomes, and selection of the reported result were the seven themes evaluated.
Results
Search Results
A total of 302 study articles resulted from the systematic search, and 45 duplicates were deleted. Title and abstract screening were conducted on 275 studies, and 210 studies were excluded. A total of 65 reports were sought for retrieval, and no articles were retrieved. Finally, 65 studies were screened for full-text assessment, 33 were excluded for wrong study outcomes and 21 for the wrong population type, and two articles were letters to the editors. Nine eligible study articles were included in this systematic review. A summary of the study selection process is presented in Figure 1.
Figure 1. PRISMA flowchart summarizes the study selection process.
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Characteristics of the Included Studies
Table 1 presents the sociodemographic characteristics of the included study articles. Our results included nine studies, with a total of 58,517 patients, and 34,398 (58.8%) were males. Three articles were cross-sectional studies, two were case controls, two were retrospective in nature, one was a randomized control trial (RCT), and one was prospective in nature.
Table 1. Sociodemographic characteristics of the included participants.
SD: Standard deviation * Minimum and maximum age are presented.
Study | Study design | Country | Participants | Mean ± SD age (years) | Males (%) |
Uchmanowicz et al., 2019 [26] | Cross-sectional | Poland | 100 | 65.5 ± 15.6 | 54 (54) |
Tam et al., 2019 [27] | RCT | China | 280 | 51.7 ± 11.9 | 204 (72.9) |
Kaya et al., 2020 [28] | Case-control | Turkey | 266 | 54.9 ± 9.1 | 204 (76.7) |
Meng et al., 2021 [29] | Case-control | China | 161 | 23-68* | 136 (84.4) |
Lee et al., 2019 [30] | Retrospective cohort | Korea | 4954 | 50.8 ± 8.5 | 2338 (47.8) |
Bouloukaki et al., 2020 [31] | Prospective cohort | Multi-centered | 4,732 | 52.4 ± 12.5 | 2,579 (55) |
Koo et al., 2022 [32] | Cross-sectional | USA | 5052 | 55.3 ± 12.8 | 1866 (36.9) |
Pefura-Yone et al., 2020 [33] | Cross-sectional | Cameroon | 8288 | 27-54* | 3709 (44.8) |
Ulander et al., 2022 [34] | Retrospective cohort | Sweden | 34684 | 55.7 ± 13.7 | 23308 (67.2) |
Table 2 presents the clinical characteristics. EDS prevalence among hypertensive patients ranged from 12.1% [30,33] to 88.3% [28]. All of the included studies reported that EDS was worse among hypertensive than normotensive patients. Older age, primary education, being overweight, working, obesity, depression, and having had the condition for longer are all associated with EDS in HTN patients [26,33,34]. Meng et al. reported that sympathovagal imbalance was seen along with EDS and HTN [29].
Table 2. Clinical characteristics and outcomes of the included studies.
NM: Not mentioned
Study | Objectives | Prevalence of EDS | Main outcomes | ROBIN-I |
Uchmanowicz et al., 2019 [26] | To assess how insomnia and EDS affect older HTN patients' quality of life (QOL). | 39 (39) | Sleep issues significantly lower QOL in HTN patients, particularly in the physical category of the QOL questionnaire. Older age, primary education, being overweight, working, and having had the condition for longer are all associated with EDS and insomnia in HTN patients. | High |
Tam et al., 2019 [27] | To see if there are any noticeable variations in EDS between hypertensive participants who have moderate to severe OSA and normal subjects. | NM | Subjective EDS was considerably worse in hypertensive patients compared to normotensive subjects with moderate to severe OSA. | NA |
Kaya et al., 2020 [28] | To identify the OSA clinical and polysomnographic characteristics that are significantly related to HTN. | 235 (88.3) | Compared to the normotensive group, the HTN group's sleep efficiency was considerably worse. | Moderate |
Meng et al., 2021 [29] | To determine whether patients with OSA shared any similar pathophysiologic factors that contributed to their reported EDS and HTN. | NM | A more severe form of the respiratory condition is OSA, accompanied by excessive EDS and HTN. Sympathovagal imbalance was seen along with EDS and HTN, and the co-occurrence of these two disorders may be connected to lower plasma ACh levels. | High |
Lee et al., 2019 [30] | To determine if age and gender affect the relationship between frequent snoring and HTN. | 283 (12.1%) | Only in men aged 45 years was frequent snoring substantially related to a 1.5 times increased risk for incident HTN than never snoring after controlling for known cardiovascular risk factors. Regardless of EDS frequent snoring was strongly linked to an increased risk for the development of HTN in this age range. | Moderate |
Bouloukaki et al., 2020 [31] | In the European Sleep Apnea Database cohort, look at the relationship between mild OSA and systemic arterial HTN. | 2129 (47) | AHI levels of less than 11 occurrences per hour were strongly linked to an increased risk of developing HTN. Despite the lack of additional daytime or sleep-related symptoms, this may result in the early identification of people at risk and treatment. | Moderate |
Koo et al., 2022 [32] | To find out if the risk factors for OSA (such as obesity, loud snoring, and EDS) differ in terms of aldosterone status from the severity and management of HTN. | 2,480 (49.1) | In adults of African American descent, risks for sleep disruptions were positively correlated with resistant HTN and higher levels of aldosterone. | Moderate |
Pefura-Yone et al., 2020 [33] | To examine the relationship between EDS and high blood pressure and to identify the causes of EDS in hypertensive people. | 1000 (12.1) | An independent link between EDS and HTN was not discovered. With HTN, obesity is linked to EDS. | Moderate |
Ulander et al., 2022 [34] | To pinpoint factors that contribute to EDS in the SESAR cohort of patients with newly diagnosed OSA. | 14740 (42.5) | Higher ESS scores were linked to depression, while lower levels were linked to atrial fibrillation and HTN. Compared to the apnea-hypopnea index, the oxygen desaturation index better predicted EDS. | Moderate |
Discussion
This systematic review reported that the prevalence of EDS among hypertensive patients ranged from 12.1% [30,33] to 88.3% [28]. There are few reports related to EDS and HTN. When used on patients with obstructive sleep apnea, Feng et al.'s research suggests that the Epworth Sleepiness Scale may serve as a predictor of BP profile [35]. Additionally, it has been shown in the past that, in contrast to patients without EDS HTN, BP in obstructive sleep apnea (OSA) patients with EDS reduced after CPAP therapy [36].
All of the included studies in this review reported that EDS was worse among hypertensive than normotensive patients [26-34]. This study suggests that subjective ratings of EDS are also linked to BP and HTN. Sleep disorders, such as obstructive sleep apnea, have been linked to BP increases and HTN [37], as well as to EDS. The correlation between EDS and BP is a significant discovery and supports earlier hypotheses that EDS can be used to identify older people at higher risk for cardiovascular problems [38]. It also emphasizes the importance of researching whether diagnosing and treating EDS can help lower BP and, eventually, reduce morbidity and death from cardiovascular diseases.
One study in this review reported that sympathovagal imbalance was seen, along with EDS and HTN [29]. The following is a proposed mechanism for how hypoxia raises BP. Chemoreceptors and baroreceptors in the carotid artery control sympathetic nerve activity. A fall in arterial blood oxygen levels activates the carotid body, which in turn stimulates the sympathetic center in the brain, stimulating the afferent nerve and causing the efferent sympathetic nervous system to become hyperactive. An elevation in BP is made possible by increased sympathetic nerve activity and a weaker baroreflex. Due to functional alterations in chemoreceptors and baroreceptors, chronic severe OSA will raise BP both during the day and at night, in addition to the transitory increase that occurs at night [39].
We found that older age, primary education, being overweight, working, obesity, depression, and having had the condition for longer are all associated with EDS in HTN patients [26,33,34]. Earlier claims that EDS can be used to identify older people who are more likely to experience cardiovascular diseases. Patients with OSA who are obese should strive to lose weight with a program that includes food counseling and exercise.
Patients' sleep habits and behavior should be evaluated, and care should be tailored to these findings. It may be necessary for a patient and/or important as part of nursing care to assess sleep patterns and practical techniques that may enhance patients' sleep. The medical staff should suggest a drug schedule in the event of persistent sleep issues. In elderly people, EDS is a prevalent but usually misinterpreted symptom. In the Cardiovascular Health Study, 20% of participants (aged 65 or older) reported feeling drowsy during the day [40]. EDS, despite commonly thought of as a benign condition, has been linked to a higher risk of cardiovascular death [41]. Additionally, although EDS is common in older populations, it may have less to do with age and be more related to the elderly's health issues [42].
There are numerous subclinical cases of OSA, even though the patient or family members typically become aware of it through symptoms such as snoring and EDS. In OSA, nighttime hypoxia and arousal frequently increase sympathetic nerve activity and raise BP during the night or early in the morning. When OSA is severe, sympathetic hyperactivity lasts all day, which causes a persistent rise in daytime BP. Atherosclerosis would eventually cause the development of cardiac and cerebrovascular illnesses in addition to HTN, and it is also known that impairment of glucose metabolism results from increased sympathetic nerve hyperactivity [11]. Actually, due to the development of comorbidities and, in particular, when oxygen saturation is decreased by sleep apnea to below 78%, and even the risk of sudden death being greatly elevated [13], it has been observed that the prognosis of severe OSA is particularly dismal [12].
One of the limitations is the scarcity of studies on the processes, and another is the high prevalence of obesity and OSA, which can have an impact on the micro- and macro-structures of sleep.
Conclusions
This review stated that individuals with HTN had EDS that was worse than that of patients with normotension. In one of the studies included in this analysis, sympathovagal imbalance was noted alongside EDS and HTN. Older age, primary education, being overweight, working, obesity, depression, and having had the condition for longer are all associated with EDS in HTN patients.
The authors have declared that no competing interests exist.
Author Contributions
Concept and design: Muteb S. Alsuwat Sr., Abdulrahman Alsuwatt, Riyadh Alamrai, Wasaif S. Alsuwat, Abdulkareem F. Al Bahis
Acquisition, analysis, or interpretation of data: Muteb S. Alsuwat Sr., Yazeed Almansouri , Mazen Alzahrani, Bader H. Almansouri
Drafting of the manuscript: Muteb S. Alsuwat Sr.
Critical review of the manuscript for important intellectual content: Muteb S. Alsuwat Sr., Yazeed Almansouri , Abdulrahman Alsuwatt, Mazen Alzahrani, Riyadh Alamrai, Wasaif S. Alsuwat, Bader H. Almansouri, Abdulkareem F. Al Bahis
Supervision: Abdulkareem F. Al Bahis
References
- 1.Stroke incidence and association with risk factors in women: a 32-year follow-up of the Prospective Population Study of Women in Gothenburg. Blomstrand A, Blomstrand C, Ariai N, Bengtsson C, Björkelund C. BMJ Open. 2014;4:0. doi: 10.1136/bmjopen-2014-005173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Impact of psychosocial factors on cardiovascular morbimortality: a prospective cohort study. Mejía-Lancheros C, Estruch R, Martínez-González MA, et al. BMC Cardiovasc Disord. 2014;14:135. doi: 10.1186/1471-2261-14-135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. O'donnell MJ, Xavier D, Liu L, et al. Lancet. 2010;376:112–123. doi: 10.1016/S0140-6736(10)60834-3. [DOI] [PubMed] [Google Scholar]
- 4.Predictive value of the SCORE, SCORE2, and pooled cohort risk equation systems in patients with hypertension. Karakayalı M, Püşüroğlu H, Altunova M, Yılmaz E, Güllü A. https://www.archivestsc.com/jvi.aspx?pdir=tkd&plng=eng&un=TKDA-74249&look4= Turk Kardiyol Dern Ars. 2023;51:407–414. doi: 10.5543/tkda.2023.74249. [DOI] [PubMed] [Google Scholar]
- 5.The relationship between the systemic immune-inflammation index and reverse-dipper circadian pattern in newly diagnosed hypertensive patients. Karakayali M, Omar T, Artac I, Rencuzogullari İ, Karabag Y, Demir O. J Clin Hypertens (Greenwich) 2023;25:700–707. doi: 10.1111/jch.14688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.The association between frontal QRS-T angle and reverse dipper status in newly diagnosed hypertensive patients. Karakayali M, Artac I, Omar T, et al. Blood Press Monit. 2023;28:96–102. doi: 10.1097/MBP.0000000000000637. [DOI] [PubMed] [Google Scholar]
- 7.Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Mills KT, Bundy JD, Kelly TN, et al. Circulation. 2016;134:441–450. doi: 10.1161/CIRCULATIONAHA.115.018912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Characterizing sleeping habits and disturbances among Saudi adults. Al-Tannir M, Kobrosly SY, Al-Badr AH, Salloum NA, Altannir YM. Saudi Med J. 2016;37:1372–1380. doi: 10.15537/smj.2016.12.17373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.[The quality and characteristics of sleep of hypertensive patients] Hanus JS, Amboni G, Rosa MI, Ceretta LB, Tuon L. Rev Esc Enferm USP. 2015;49:596–602. doi: 10.1590/S0080-623420150000400009. [DOI] [PubMed] [Google Scholar]
- 10.Association of sleep duration, sleep quality and shift-work schedule in relation to hypertension prevalence in Chinese adult males: a cross-sectional survey. Lu K, Chen J, Wang L, Wang C, Ding R, Wu S, Hu D. Int J Environ Res Public Health. 2017;14:210. doi: 10.3390/ijerph14020210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sleep disturbances and cause-specific mortality: results from the GAZEL cohort study. Rod NH, Vahtera J, Westerlund H, Kivimaki M, Zins M, Goldberg M, Lange T. Am J Epidemiol. 2011;173:300–309. doi: 10.1093/aje/kwq371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sleep, insomnia, and hypertension: current findings and future directions. Thomas SJ, Calhoun D. J Am Soc Hypertens. 2017;11:122–129. doi: 10.1016/j.jash.2016.11.008. [DOI] [PubMed] [Google Scholar]
- 13.Effects of inadequate sleep on blood pressure and endothelial inflammation in women: findings from the American Heart Association go red for women strategically focused research network. Aggarwal B, Makarem N, Shah R, Emin M, Wei Y, St-Onge MP, Jelic S. J Am Heart Assoc. 2018;7:0. doi: 10.1161/JAHA.118.008590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sleep disturbances and resistant hypertension in a large sample of treated hypertensive subjects-POL-FOKUS study. Talarowska P, Klocek M, Gasowski J, et al. J Hypertens. 2017;35:0–4. [Google Scholar]
- 15.The impact of the improvement of insomnia on blood pressure in hypertensive patients. Li Y, Yang Y, Li Q, Yang X, Wang Y, Ku WL, Li H. J Sleep Res. 2017;26:105–114. doi: 10.1111/jsr.12411. [DOI] [PubMed] [Google Scholar]
- 16.Epidemiological overview of sleep disorders in the general population. Ohayon MM. Sleep Med Res. 2011;2:1–9. [Google Scholar]
- 17.Sleepiness, near-misses and driving accidents among a representative population of French drivers. Sagaspe P, Taillard J, Bayon V, et al. J Sleep Res. 2010;19:578–584. doi: 10.1111/j.1365-2869.2009.00818.x. [DOI] [PubMed] [Google Scholar]
- 18.What are the important risk factors for daytime sleepiness and fatigue in women? Theorell-Haglöw J, Lindberg E, Janson C. Sleep. 2006;29:751–757. doi: 10.1093/sleep/29.6.751. [DOI] [PubMed] [Google Scholar]
- 19.Prevalence of excessive daytime sleepiness and associated factors in the adult population of Korea. Joo S, Baik I, Yi H, Jung K, Kim J, Shin C. Sleep Med. 2009;10:182–188. doi: 10.1016/j.sleep.2008.03.017. [DOI] [PubMed] [Google Scholar]
- 20.Prevalence of and associations with excessive daytime sleepiness in an Australian older population. Vashum KP, McEvoy MA, Hancock SJ, Islam MR, Peel R, Attia JR, Milton AH. Asia Pac J Public Health. 2015;27:0–84. doi: 10.1177/1010539513497783. [DOI] [PubMed] [Google Scholar]
- 21.The association between the phenotype of excessive daytime sleepiness and blood pressure in patients with obstructive sleep apnea-hypopnea syndrome. Wang Q, Zhang C, Jia P, et al. Int J Med Sci. 2014;11:713–720. doi: 10.7150/ijms.7487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.The influence of hypertension on daytime sleepiness in obstructive sleep apnea. Martynowicz H, Skomro R, Gać P, et al. J Am Soc Hypertens. 2017;11:295–302. doi: 10.1016/j.jash.2017.03.004. [DOI] [PubMed] [Google Scholar]
- 23.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. Int J Surg. 2021;88:105906. doi: 10.1016/j.ijsu.2021.105906. [DOI] [PubMed] [Google Scholar]
- 24.Rayyan-a web and mobile app for systematic reviews. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Syst Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance. Jüni P, Loke Y, Pigott T, et al. https://www.msg.ugent.be/wp-content/uploads/2019/10/ROBINS-I_detailed_guidance.pdf Br Med J. 2016;355:4919. [Google Scholar]
- 26.The relationship between sleep disturbances and quality of life in elderly patients with hypertension. Uchmanowicz I, Markiewicz K, Uchmanowicz B, Kołtuniuk A, Rosińczuk J. Clin Interv Aging. 2019;14:155–165. doi: 10.2147/CIA.S188499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness. Tam W, Ng SS, To KW, Ko FW, Hui DS. J Clin Hypertens (Greenwich) 2019;21:390–396. doi: 10.1111/jch.13485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Clinical and polysomnographic features of hypertension in obstructive sleep apnea: a single-center cross-sectional study. Gürün Kaya A, Gülbay B, Acıcan T. Anatol J Cardiol. 2020;23:334–341. doi: 10.14744/AnatolJCardiol.2020.71429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Depression of non-neuronal cholinergic system may play a role in co-occurrence of subjective daytime sleepiness and hypertension in patients with obstructive sleep apnea syndrome. Meng Z, Sun B, Chen W, Zhang X, Huang M, Xu J. Nat Sci Sleep. 2021;13:2153–2163. doi: 10.2147/NSS.S339038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Increased risk for new-onset hypertension in midlife male snorers: the 14-year follow-up study. Lee SK, Choi K, Chang YH, Kim J, Shin C. J Sleep Res. 2019;28:0. doi: 10.1111/jsr.12757. [DOI] [PubMed] [Google Scholar]
- 31.Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification. Bouloukaki I, Grote L, McNicholas WT, et al. J Clin Sleep Med. 2020;16:889–898. doi: 10.5664/jcsm.8354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Relationship between risks for obstructive sleep apnea, resistant hypertension, and aldosterone among African American adults in the Jackson Heart Study. Koo P, Muntner P, Hall ME, Gjelsvik A, McCool FD, Eaton CB. Am J Hypertens. 2022;35:875–883. doi: 10.1093/ajh/hpac091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Excessive daytime sleepiness and hypertension in Cameroonian adult population. Pefura-Yone E, Kamga OJ, Balkissou AD, et al. Am J Intern Med. 2020;8:8–13. [Google Scholar]
- 34.Correlates of excessive daytime sleepiness in obstructive sleep apnea: results from the nationwide SESAR cohort including 34,684 patients. Ulander M, Hedner J, Stillberg G, Sunnergren O, Grote L. J Sleep Res. 2022;31:0. doi: 10.1111/jsr.13690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Epworth sleepiness scale may be an indicator for blood pressure profile and prevalence of coronary artery disease and cerebrovascular disease in patients with obstructive sleep apnea. Feng J, He QY, Zhang XL, Chen BY. Sleep Breath. 2012;16:31–40. doi: 10.1007/s11325-011-0481-5. [DOI] [PubMed] [Google Scholar]
- 36.Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Barbé F, Mayoralas LR, Duran J, et al. Ann Intern Med. 2001;134:1015–1023. doi: 10.7326/0003-4819-134-11-200106050-00007. [DOI] [PubMed] [Google Scholar]
- 37.Systemic hypertension and obstructive sleep apnoea. Pepperell JC, Davies RJ, Stradling JR. Sleep Med Rev. 2002;6:157–173. doi: 10.1053/smrv.2001.0189. [DOI] [PubMed] [Google Scholar]
- 38.Daytime sleepiness predicts mortality and cardiovascular disease in older adults. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, Robbins J. J Am Geriatr Soc. 2000;48:115–123. doi: 10.1111/j.1532-5415.2000.tb03901.x. [DOI] [PubMed] [Google Scholar]
- 39.Peripheral chemoreceptors: function and plasticity of the carotid body. Kumar P, Prabhakar NR. Compr Physiol. 2012;2:141–219. doi: 10.1002/cphy.c100069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Zhou B, Bentham J, Di Cesare M, et al. Lancet. 2017;389:37–55. doi: 10.1016/S0140-6736(16)31919-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ash/ASPC/NMA/PCNA guideline for the Prevention, Detection, Evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinic. Whelton PK, Carey RM, Aronow WS, et al. Hypertension. 2018;71:0. doi: 10.1161/HYP.0000000000000065. [DOI] [PubMed] [Google Scholar]
- 42.Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Funder JW, Carey RM, Fardella C, et al. J Clin Endocrinol Metab. 2008;93:3266–3281. doi: 10.1210/jc.2008-0104. [DOI] [PubMed] [Google Scholar]